You are here:

Home
NICE Guidance
Conditions and diseases
Cancer
Oesophageal cancer

Oesophageal cancer Products

A list of all our products on oesophageal cancer

Filter

Product type

Product typeGuidanceQuality standards

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceHealthTech guidance

Status
1 selected

StatusPublishedIn consultationIn developmentAwaiting development

New and updated

New and updatedNew in the last 6 monthsUpdated in the last 6 months

Showing 1 product

Sort by: Date | Sort by Title

Status: In consultationRemove ‘Status: In consultation’ filter

Zanidatamab with chemotherapy with or without tislelizumab for untreated HER2-positive unresectable advanced gastro-oesophageal adenocarcinoma ID6672
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
15 June 2026
Expected publication date:
TBC